Select Medical Holdings (SEM) Net Income towards Common Stockholders (2018 - 2026)

Select Medical Holdings has disclosed Net Income towards Common Stockholders across 9 years of filings, most recently posting $63.8 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 120.08% year-over-year to $63.8 million; the TTM figure through Mar 2026 stood at -$893.2 million (down 73.97% YoY), while the FY2025 annual figure was -$311.3 million, down 98.3% from the prior year.
• Net Income towards Common Stockholders climbed to $63.8 million in Q1 2026, from -$311.3 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for SEM reached as high as $66.3 million in Q2 2022 and fell as low as -$376.4 million in Q4 2022.
• The 5-year median for Net Income towards Common Stockholders is $39.7 million (2024), against an average of -$95.7 million.
• Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders tumbled 910.12% — and 2026, when it jumped 120.08%.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$376.4 million in 2022, then jumped by 39.46% to -$227.9 million in 2023, then retreated by 27.86% to -$291.4 million in 2024, then fell by 6.86% to -$311.3 million in 2025, then soared by 120.48% to $63.8 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $63.8 million, -$311.3 million, and -$321.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.